Prostate cancer project aims to spare men unnecessary treatment
A new £1.4 million research project aims to help doctors better predict which prostate cancers are likely to become dangerous. If successful, it could help some men avoid unnecessary biopsies and treatment, while helping others with aggressive cancer receive care sooner.
The project, called REIMAGINE[Life], is led by Professor Mieke Van Hemelrijck at King’s College London, working with researchers at University College London, Imperial College London and Radboud University. It is funded by Prostate Cancer UK and the John Black Charitable Foundation.
Using existing scans, tests and NHS records
Researchers will study information from more than 1,000 men who have already had detailed MRI scans and samples taken. By linking those records with NHS data, the team hopes to understand how the men’s cancers developed over time.
The researchers will use computer models to look for patterns across MRI scans, biopsy samples, blood and urine tests, genetic information and clinical records. Their goal is to develop a tool that can better estimate whether a cancer is likely to remain low risk or grow and spread.
The project is due to start on 10 December 2026, according to The Times’ report on the prostate cancer research. Further details are available from Prostate Cancer UK.
Why predicting cancer risk matters
Prostate cancer does not behave in the same way in every man. Some cancers grow slowly and may not cause serious problems for many years. Others can become life-threatening and need prompt treatment.
At present, doctors consider a range of information when assessing a patient, including biopsy results and MRI scans. But predicting how an individual cancer will behave can remain difficult. That uncertainty can make treatment decisions challenging. Some men may experience side effects from treatment they might not have needed, while aggressive cancer may not always be identified quickly.
The proposed tool is still being developed and assessed. It is not yet a diagnostic test that men can request, and the project’s potential benefits will depend on how well it performs when tested against what happens to patients over time.
Prostate cancer diagnosis and delayed treatment
Research into more accurate diagnosis is welcome, but it does not change the importance of investigating symptoms and test results appropriately. A delay in diagnosis does not automatically mean that anyone was negligent. A claim would depend on the individual circumstances, including whether care fell below the expected standard and whether that caused avoidable harm.
Our page on delayed prostate cancer diagnosis claims explains more. You can also read about delayed cancer diagnosis compensation.
Contact Us Now To Claim
